Global GABA Receptor Modulators Market Growth (Status and Outlook) 2026-2032
The global GABA Receptor Modulators market size is predicted to grow from US$ 10859 million in 2025 to US$ 14864 million in 2032; it is expected to grow at a CAGR of 4.6% from 2026 to 2032.
GABA receptor modulators are prescription medicines that act directly on GABAA or GABAB receptors and alter inhibitory neurotransmission through agonism, positive allosteric modulation, or receptor antagonism. Commercial products mainly include benzodiazepines, Z-drug hypnotics, barbiturates, selected intravenous anesthetics and sedatives, neuroactive steroids, baclofen, and oxybate-based medicines. Clinical applications include anxiety disorders, insomnia, epilepsy and seizures, anesthesia and procedural sedation, spasticity, narcolepsy, idiopathic hypersomnia, and postpartum depression. Major dosage forms include tablets, capsules, oral liquids, oral suspensions, injectable products, intravenous emulsions, nasal sprays, oromucosal products, and intrathecal injections. Upstream inputs mainly include active pharmaceutical ingredients, pharmaceutical excipients, emulsion oils, phospholipids, solubilizers, extended-release materials, sterile injectable components, drug-delivery devices, and pharmaceutical packaging. Downstream customers mainly include general hospitals, psychiatric hospitals, neurology departments, sleep medicine centers, epilepsy centers, operating rooms, rehabilitation institutions, specialty pharmacies, and pharmaceutical distributors. Competition is intense in mature oral generics, while neuroactive steroids, oxybate products, nasal sprays, complex intravenous emulsions, and intrathecal formulations retain higher added value, with an overall gross margin generally ranging from approximately 50% to 76%.
From the current market perspective, the GABA receptor modulator market consists of a large base of mature generic products and a smaller group of high-value innovative or differentiated medicines. Benzodiazepines, Z-drugs, barbiturates, midazolam, propofol, and baclofen have established clinical roles in anxiety, insomnia, epilepsy, anesthesia, sedation, and spasticity. Oxybate products, neuroactive steroids, remimazolam, and outpatient seizure-rescue products serve smaller patient populations but contribute disproportionately to market value.
Looking ahead, GABAA drug development will increasingly focus on receptor-subunit selectivity, extrasynaptic receptor modulation, neurosteroid binding sites, and mechanisms with lower dependence potential. The aim is to reduce next-day impairment, respiratory depression, cognitive effects, tolerance, and dependence. GABAB development will emphasize lower-sodium oxybate formulations, once-at-bedtime dosing, liquid baclofen products for pediatric and dysphagic patients, and intrathecal therapy for severe spasticity.
Key market drivers include the large patient populations affected by anxiety, insomnia, epilepsy, narcolepsy, idiopathic hypersomnia, multiple sclerosis, and spinal cord injury. Population aging, increasing surgical and endoscopic procedure volumes, improved sleep and mental health services, and greater rare-disease diagnosis support hospital and specialty-market demand. Low-sodium formulations, extended-release delivery, nasal administration, and neuroactive steroids are expanding the clinical scope of GABA-targeted therapies.
The main constraints include central nervous system depression, somnolence, cognitive and motor impairment, falls, respiratory depression, tolerance, dependence, misuse, and withdrawal. Benzodiazepines, Z-drugs, and oxybate products are subject to strict prescription and controlled-drug requirements, while oxybates also rely on restricted distribution systems. Generic competition, procurement pressure, insurance access, rebates, non-pharmacological treatment, and newer-mechanism medicines may limit growth in mature segments.
LPI (LP Information)' newest research report, the “GABA Receptor Modulators Industry Forecast” looks at past sales and reviews total world GABA Receptor Modulators sales in 2025, providing a comprehensive analysis by region and market sector of projected GABA Receptor Modulators sales for 2026 through 2032. With GABA Receptor Modulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GABA Receptor Modulators industry.
This Insight Report provides a comprehensive analysis of the global GABA Receptor Modulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GABA Receptor Modulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GABA Receptor Modulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GABA Receptor Modulators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GABA Receptor Modulators.
This report presents a comprehensive overview, market shares, and growth opportunities of GABA Receptor Modulators market by product type, application, key players and key regions and countries.
GABA receptor modulators are prescription medicines that act directly on GABAA or GABAB receptors and alter inhibitory neurotransmission through agonism, positive allosteric modulation, or receptor antagonism. Commercial products mainly include benzodiazepines, Z-drug hypnotics, barbiturates, selected intravenous anesthetics and sedatives, neuroactive steroids, baclofen, and oxybate-based medicines. Clinical applications include anxiety disorders, insomnia, epilepsy and seizures, anesthesia and procedural sedation, spasticity, narcolepsy, idiopathic hypersomnia, and postpartum depression. Major dosage forms include tablets, capsules, oral liquids, oral suspensions, injectable products, intravenous emulsions, nasal sprays, oromucosal products, and intrathecal injections. Upstream inputs mainly include active pharmaceutical ingredients, pharmaceutical excipients, emulsion oils, phospholipids, solubilizers, extended-release materials, sterile injectable components, drug-delivery devices, and pharmaceutical packaging. Downstream customers mainly include general hospitals, psychiatric hospitals, neurology departments, sleep medicine centers, epilepsy centers, operating rooms, rehabilitation institutions, specialty pharmacies, and pharmaceutical distributors. Competition is intense in mature oral generics, while neuroactive steroids, oxybate products, nasal sprays, complex intravenous emulsions, and intrathecal formulations retain higher added value, with an overall gross margin generally ranging from approximately 50% to 76%.
From the current market perspective, the GABA receptor modulator market consists of a large base of mature generic products and a smaller group of high-value innovative or differentiated medicines. Benzodiazepines, Z-drugs, barbiturates, midazolam, propofol, and baclofen have established clinical roles in anxiety, insomnia, epilepsy, anesthesia, sedation, and spasticity. Oxybate products, neuroactive steroids, remimazolam, and outpatient seizure-rescue products serve smaller patient populations but contribute disproportionately to market value.
Looking ahead, GABAA drug development will increasingly focus on receptor-subunit selectivity, extrasynaptic receptor modulation, neurosteroid binding sites, and mechanisms with lower dependence potential. The aim is to reduce next-day impairment, respiratory depression, cognitive effects, tolerance, and dependence. GABAB development will emphasize lower-sodium oxybate formulations, once-at-bedtime dosing, liquid baclofen products for pediatric and dysphagic patients, and intrathecal therapy for severe spasticity.
Key market drivers include the large patient populations affected by anxiety, insomnia, epilepsy, narcolepsy, idiopathic hypersomnia, multiple sclerosis, and spinal cord injury. Population aging, increasing surgical and endoscopic procedure volumes, improved sleep and mental health services, and greater rare-disease diagnosis support hospital and specialty-market demand. Low-sodium formulations, extended-release delivery, nasal administration, and neuroactive steroids are expanding the clinical scope of GABA-targeted therapies.
The main constraints include central nervous system depression, somnolence, cognitive and motor impairment, falls, respiratory depression, tolerance, dependence, misuse, and withdrawal. Benzodiazepines, Z-drugs, and oxybate products are subject to strict prescription and controlled-drug requirements, while oxybates also rely on restricted distribution systems. Generic competition, procurement pressure, insurance access, rebates, non-pharmacological treatment, and newer-mechanism medicines may limit growth in mature segments.
LPI (LP Information)' newest research report, the “GABA Receptor Modulators Industry Forecast” looks at past sales and reviews total world GABA Receptor Modulators sales in 2025, providing a comprehensive analysis by region and market sector of projected GABA Receptor Modulators sales for 2026 through 2032. With GABA Receptor Modulators sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GABA Receptor Modulators industry.
This Insight Report provides a comprehensive analysis of the global GABA Receptor Modulators landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GABA Receptor Modulators portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GABA Receptor Modulators market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GABA Receptor Modulators and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GABA Receptor Modulators.
This report presents a comprehensive overview, market shares, and growth opportunities of GABA Receptor Modulators market by product type, application, key players and key regions and countries.
Segmentation by Type:
- GABAA Receptor Modulators
- GABAB Receptor Modulators
Segmentation by Pharmacological Class:
- Benzodiazepines
- Z-drugs
- Barbiturates
- Other
Segmentation by Dosage Form:
- Tablets and Capsules
- Oral Liquids and Suspensions
- Injectable Solutions
- Other
Segmentation by Application:
- Hospital
- Clinic
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Viatris
- Teva Pharmaceutical Industries
- Sandoz
- Hikma Pharmaceuticals
- Fresenius Kabi
- B. Braun
- UCB
- Neurelis
- Eagle Pharmaceuticals
- Cosette Pharmaceuticals
- Supernus Pharmaceuticals
- Biogen
- Immedica Pharma
- Jazz Pharmaceuticals
- Alkermes
- Amneal Pharmaceuticals
- Azurity Pharmaceuticals
- Piramal Pharma
- Humanwell Healthcare Group
- Jiangsu Nhwa Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GABA Receptor Modulators Market Size (2021-2032)
2.1.2 GABA Receptor Modulators Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for GABA Receptor Modulators by Country/Region (2021, 2025 & 2032)
2.2 GABA Receptor Modulators Segment by Type
2.2.1 GABAA Receptor Modulators
2.2.2 GABAB Receptor Modulators
2.2.3 GABA Receptor Modulators Market Size by Type
2.2.3.1 GABA Receptor Modulators Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
2.3 GABA Receptor Modulators Segment by Pharmacological Class
2.3.1 Benzodiazepines
2.3.2 Z-drugs
2.3.3 Barbiturates
2.3.4 Other
2.3.5 GABA Receptor Modulators Market Size by Pharmacological Class
2.3.5.1 GABA Receptor Modulators Market Size CAGR by Pharmacological Class (2021 VS 2025 VS 2032)
2.3.5.2 Global GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2021-2026)
2.4 GABA Receptor Modulators Segment by Dosage Form
2.4.1 Tablets and Capsules
2.4.2 Oral Liquids and Suspensions
2.4.3 Injectable Solutions
2.4.4 Other
2.4.5 GABA Receptor Modulators Market Size by Dosage Form
2.4.5.1 GABA Receptor Modulators Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032)
2.4.5.2 Global GABA Receptor Modulators Market Size Market Share by Dosage Form (2021-2026)
2.5 GABA Receptor Modulators Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 GABA Receptor Modulators Market Size by Application
2.5.4.1 GABA Receptor Modulators Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
3 GABA RECEPTOR MODULATORS MARKET SIZE BY PLAYER
3.1 GABA Receptor Modulators Market Size Market Share by Player
3.1.1 Global GABA Receptor Modulators Revenue by Player (2021-2026)
3.1.2 Global GABA Receptor Modulators Revenue Market Share by Player (2021-2026)
3.2 Global GABA Receptor Modulators Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GABA RECEPTOR MODULATORS BY REGION
4.1 GABA Receptor Modulators Market Size by Region (2021-2026)
4.2 Global GABA Receptor Modulators Annual Revenue by Country/Region (2021-2026)
4.3 Americas GABA Receptor Modulators Market Size Growth (2021-2026)
4.4 APAC GABA Receptor Modulators Market Size Growth (2021-2026)
4.5 Europe GABA Receptor Modulators Market Size Growth (2021-2026)
4.6 Middle East & Africa GABA Receptor Modulators Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas GABA Receptor Modulators Market Size by Country (2021-2026)
5.2 Americas GABA Receptor Modulators Market Size by Type (2021-2026)
5.3 Americas GABA Receptor Modulators Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GABA Receptor Modulators Market Size by Region (2021-2026)
6.2 APAC GABA Receptor Modulators Market Size by Type (2021-2026)
6.3 APAC GABA Receptor Modulators Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe GABA Receptor Modulators Market Size by Country (2021-2026)
7.2 Europe GABA Receptor Modulators Market Size by Type (2021-2026)
7.3 Europe GABA Receptor Modulators Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GABA Receptor Modulators by Region (2021-2026)
8.2 Middle East & Africa GABA Receptor Modulators Market Size by Type (2021-2026)
8.3 Middle East & Africa GABA Receptor Modulators Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GABA RECEPTOR MODULATORS MARKET FORECAST
10.1 Global GABA Receptor Modulators Forecast by Region (2027-2032)
10.1.1 Global GABA Receptor Modulators Forecast by Region (2027-2032)
10.1.2 Americas GABA Receptor Modulators Forecast
10.1.3 APAC GABA Receptor Modulators Forecast
10.1.4 Europe GABA Receptor Modulators Forecast
10.1.5 Middle East & Africa GABA Receptor Modulators Forecast
10.2 Americas GABA Receptor Modulators Forecast by Country (2027-2032)
10.2.1 United States Market GABA Receptor Modulators Forecast
10.2.2 Canada Market GABA Receptor Modulators Forecast
10.2.3 Mexico Market GABA Receptor Modulators Forecast
10.2.4 Brazil Market GABA Receptor Modulators Forecast
10.3 APAC GABA Receptor Modulators Forecast by Region (2027-2032)
10.3.1 China GABA Receptor Modulators Market Forecast
10.3.2 Japan Market GABA Receptor Modulators Forecast
10.3.3 Korea Market GABA Receptor Modulators Forecast
10.3.4 Southeast Asia Market GABA Receptor Modulators Forecast
10.3.5 India Market GABA Receptor Modulators Forecast
10.3.6 Australia Market GABA Receptor Modulators Forecast
10.4 Europe GABA Receptor Modulators Forecast by Country (2027-2032)
10.4.1 Germany Market GABA Receptor Modulators Forecast
10.4.2 France Market GABA Receptor Modulators Forecast
10.4.3 UK Market GABA Receptor Modulators Forecast
10.4.4 Italy Market GABA Receptor Modulators Forecast
10.4.5 Russia Market GABA Receptor Modulators Forecast
10.5 Middle East & Africa GABA Receptor Modulators Forecast by Region (2027-2032)
10.5.1 Egypt Market GABA Receptor Modulators Forecast
10.5.2 South Africa Market GABA Receptor Modulators Forecast
10.5.3 Israel Market GABA Receptor Modulators Forecast
10.5.4 Turkey Market GABA Receptor Modulators Forecast
10.6 Global GABA Receptor Modulators Forecast by Type (2027-2032)
10.7 Global GABA Receptor Modulators Forecast by Application (2027-2032)
10.7.1 GCC Countries Market GABA Receptor Modulators Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer GABA Receptor Modulators Product Offered
11.1.3 Pfizer GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Viatris
11.2.1 Viatris Company Information
11.2.2 Viatris GABA Receptor Modulators Product Offered
11.2.3 Viatris GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Viatris Main Business Overview
11.2.5 Viatris Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries GABA Receptor Modulators Product Offered
11.3.3 Teva Pharmaceutical Industries GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 Sandoz
11.4.1 Sandoz Company Information
11.4.2 Sandoz GABA Receptor Modulators Product Offered
11.4.3 Sandoz GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sandoz Main Business Overview
11.4.5 Sandoz Latest Developments
11.5 Hikma Pharmaceuticals
11.5.1 Hikma Pharmaceuticals Company Information
11.5.2 Hikma Pharmaceuticals GABA Receptor Modulators Product Offered
11.5.3 Hikma Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hikma Pharmaceuticals Main Business Overview
11.5.5 Hikma Pharmaceuticals Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi GABA Receptor Modulators Product Offered
11.6.3 Fresenius Kabi GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 B. Braun
11.7.1 B. Braun Company Information
11.7.2 B. Braun GABA Receptor Modulators Product Offered
11.7.3 B. Braun GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 B. Braun Main Business Overview
11.7.5 B. Braun Latest Developments
11.8 UCB
11.8.1 UCB Company Information
11.8.2 UCB GABA Receptor Modulators Product Offered
11.8.3 UCB GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 UCB Main Business Overview
11.8.5 UCB Latest Developments
11.9 Neurelis
11.9.1 Neurelis Company Information
11.9.2 Neurelis GABA Receptor Modulators Product Offered
11.9.3 Neurelis GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Neurelis Main Business Overview
11.9.5 Neurelis Latest Developments
11.10 Eagle Pharmaceuticals
11.10.1 Eagle Pharmaceuticals Company Information
11.10.2 Eagle Pharmaceuticals GABA Receptor Modulators Product Offered
11.10.3 Eagle Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eagle Pharmaceuticals Main Business Overview
11.10.5 Eagle Pharmaceuticals Latest Developments
11.11 Cosette Pharmaceuticals
11.11.1 Cosette Pharmaceuticals Company Information
11.11.2 Cosette Pharmaceuticals GABA Receptor Modulators Product Offered
11.11.3 Cosette Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cosette Pharmaceuticals Main Business Overview
11.11.5 Cosette Pharmaceuticals Latest Developments
11.12 Supernus Pharmaceuticals
11.12.1 Supernus Pharmaceuticals Company Information
11.12.2 Supernus Pharmaceuticals GABA Receptor Modulators Product Offered
11.12.3 Supernus Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Supernus Pharmaceuticals Main Business Overview
11.12.5 Supernus Pharmaceuticals Latest Developments
11.13 Biogen
11.13.1 Biogen Company Information
11.13.2 Biogen GABA Receptor Modulators Product Offered
11.13.3 Biogen GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Biogen Main Business Overview
11.13.5 Biogen Latest Developments
11.14 Immedica Pharma
11.14.1 Immedica Pharma Company Information
11.14.2 Immedica Pharma GABA Receptor Modulators Product Offered
11.14.3 Immedica Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Immedica Pharma Main Business Overview
11.14.5 Immedica Pharma Latest Developments
11.15 Jazz Pharmaceuticals
11.15.1 Jazz Pharmaceuticals Company Information
11.15.2 Jazz Pharmaceuticals GABA Receptor Modulators Product Offered
11.15.3 Jazz Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Jazz Pharmaceuticals Main Business Overview
11.15.5 Jazz Pharmaceuticals Latest Developments
11.16 Alkermes
11.16.1 Alkermes Company Information
11.16.2 Alkermes GABA Receptor Modulators Product Offered
11.16.3 Alkermes GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Alkermes Main Business Overview
11.16.5 Alkermes Latest Developments
11.17 Amneal Pharmaceuticals
11.17.1 Amneal Pharmaceuticals Company Information
11.17.2 Amneal Pharmaceuticals GABA Receptor Modulators Product Offered
11.17.3 Amneal Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Amneal Pharmaceuticals Main Business Overview
11.17.5 Amneal Pharmaceuticals Latest Developments
11.18 Azurity Pharmaceuticals
11.18.1 Azurity Pharmaceuticals Company Information
11.18.2 Azurity Pharmaceuticals GABA Receptor Modulators Product Offered
11.18.3 Azurity Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Azurity Pharmaceuticals Main Business Overview
11.18.5 Azurity Pharmaceuticals Latest Developments
11.19 Piramal Pharma
11.19.1 Piramal Pharma Company Information
11.19.2 Piramal Pharma GABA Receptor Modulators Product Offered
11.19.3 Piramal Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Piramal Pharma Main Business Overview
11.19.5 Piramal Pharma Latest Developments
11.20 Humanwell Healthcare Group
11.20.1 Humanwell Healthcare Group Company Information
11.20.2 Humanwell Healthcare Group GABA Receptor Modulators Product Offered
11.20.3 Humanwell Healthcare Group GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Humanwell Healthcare Group Main Business Overview
11.20.5 Humanwell Healthcare Group Latest Developments
11.21 Jiangsu Nhwa Pharmaceutical
11.21.1 Jiangsu Nhwa Pharmaceutical Company Information
11.21.2 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product Offered
11.21.3 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
11.21.5 Jiangsu Nhwa Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GABA Receptor Modulators Market Size (2021-2032)
2.1.2 GABA Receptor Modulators Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for GABA Receptor Modulators by Country/Region (2021, 2025 & 2032)
2.2 GABA Receptor Modulators Segment by Type
2.2.1 GABAA Receptor Modulators
2.2.2 GABAB Receptor Modulators
2.2.3 GABA Receptor Modulators Market Size by Type
2.2.3.1 GABA Receptor Modulators Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
2.3 GABA Receptor Modulators Segment by Pharmacological Class
2.3.1 Benzodiazepines
2.3.2 Z-drugs
2.3.3 Barbiturates
2.3.4 Other
2.3.5 GABA Receptor Modulators Market Size by Pharmacological Class
2.3.5.1 GABA Receptor Modulators Market Size CAGR by Pharmacological Class (2021 VS 2025 VS 2032)
2.3.5.2 Global GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2021-2026)
2.4 GABA Receptor Modulators Segment by Dosage Form
2.4.1 Tablets and Capsules
2.4.2 Oral Liquids and Suspensions
2.4.3 Injectable Solutions
2.4.4 Other
2.4.5 GABA Receptor Modulators Market Size by Dosage Form
2.4.5.1 GABA Receptor Modulators Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032)
2.4.5.2 Global GABA Receptor Modulators Market Size Market Share by Dosage Form (2021-2026)
2.5 GABA Receptor Modulators Segment by Application
2.5.1 Hospital
2.5.2 Clinic
2.5.3 Others
2.5.4 GABA Receptor Modulators Market Size by Application
2.5.4.1 GABA Receptor Modulators Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
3 GABA RECEPTOR MODULATORS MARKET SIZE BY PLAYER
3.1 GABA Receptor Modulators Market Size Market Share by Player
3.1.1 Global GABA Receptor Modulators Revenue by Player (2021-2026)
3.1.2 Global GABA Receptor Modulators Revenue Market Share by Player (2021-2026)
3.2 Global GABA Receptor Modulators Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GABA RECEPTOR MODULATORS BY REGION
4.1 GABA Receptor Modulators Market Size by Region (2021-2026)
4.2 Global GABA Receptor Modulators Annual Revenue by Country/Region (2021-2026)
4.3 Americas GABA Receptor Modulators Market Size Growth (2021-2026)
4.4 APAC GABA Receptor Modulators Market Size Growth (2021-2026)
4.5 Europe GABA Receptor Modulators Market Size Growth (2021-2026)
4.6 Middle East & Africa GABA Receptor Modulators Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas GABA Receptor Modulators Market Size by Country (2021-2026)
5.2 Americas GABA Receptor Modulators Market Size by Type (2021-2026)
5.3 Americas GABA Receptor Modulators Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GABA Receptor Modulators Market Size by Region (2021-2026)
6.2 APAC GABA Receptor Modulators Market Size by Type (2021-2026)
6.3 APAC GABA Receptor Modulators Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe GABA Receptor Modulators Market Size by Country (2021-2026)
7.2 Europe GABA Receptor Modulators Market Size by Type (2021-2026)
7.3 Europe GABA Receptor Modulators Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GABA Receptor Modulators by Region (2021-2026)
8.2 Middle East & Africa GABA Receptor Modulators Market Size by Type (2021-2026)
8.3 Middle East & Africa GABA Receptor Modulators Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GABA RECEPTOR MODULATORS MARKET FORECAST
10.1 Global GABA Receptor Modulators Forecast by Region (2027-2032)
10.1.1 Global GABA Receptor Modulators Forecast by Region (2027-2032)
10.1.2 Americas GABA Receptor Modulators Forecast
10.1.3 APAC GABA Receptor Modulators Forecast
10.1.4 Europe GABA Receptor Modulators Forecast
10.1.5 Middle East & Africa GABA Receptor Modulators Forecast
10.2 Americas GABA Receptor Modulators Forecast by Country (2027-2032)
10.2.1 United States Market GABA Receptor Modulators Forecast
10.2.2 Canada Market GABA Receptor Modulators Forecast
10.2.3 Mexico Market GABA Receptor Modulators Forecast
10.2.4 Brazil Market GABA Receptor Modulators Forecast
10.3 APAC GABA Receptor Modulators Forecast by Region (2027-2032)
10.3.1 China GABA Receptor Modulators Market Forecast
10.3.2 Japan Market GABA Receptor Modulators Forecast
10.3.3 Korea Market GABA Receptor Modulators Forecast
10.3.4 Southeast Asia Market GABA Receptor Modulators Forecast
10.3.5 India Market GABA Receptor Modulators Forecast
10.3.6 Australia Market GABA Receptor Modulators Forecast
10.4 Europe GABA Receptor Modulators Forecast by Country (2027-2032)
10.4.1 Germany Market GABA Receptor Modulators Forecast
10.4.2 France Market GABA Receptor Modulators Forecast
10.4.3 UK Market GABA Receptor Modulators Forecast
10.4.4 Italy Market GABA Receptor Modulators Forecast
10.4.5 Russia Market GABA Receptor Modulators Forecast
10.5 Middle East & Africa GABA Receptor Modulators Forecast by Region (2027-2032)
10.5.1 Egypt Market GABA Receptor Modulators Forecast
10.5.2 South Africa Market GABA Receptor Modulators Forecast
10.5.3 Israel Market GABA Receptor Modulators Forecast
10.5.4 Turkey Market GABA Receptor Modulators Forecast
10.6 Global GABA Receptor Modulators Forecast by Type (2027-2032)
10.7 Global GABA Receptor Modulators Forecast by Application (2027-2032)
10.7.1 GCC Countries Market GABA Receptor Modulators Forecast
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer GABA Receptor Modulators Product Offered
11.1.3 Pfizer GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Viatris
11.2.1 Viatris Company Information
11.2.2 Viatris GABA Receptor Modulators Product Offered
11.2.3 Viatris GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Viatris Main Business Overview
11.2.5 Viatris Latest Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Information
11.3.2 Teva Pharmaceutical Industries GABA Receptor Modulators Product Offered
11.3.3 Teva Pharmaceutical Industries GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Teva Pharmaceutical Industries Main Business Overview
11.3.5 Teva Pharmaceutical Industries Latest Developments
11.4 Sandoz
11.4.1 Sandoz Company Information
11.4.2 Sandoz GABA Receptor Modulators Product Offered
11.4.3 Sandoz GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Sandoz Main Business Overview
11.4.5 Sandoz Latest Developments
11.5 Hikma Pharmaceuticals
11.5.1 Hikma Pharmaceuticals Company Information
11.5.2 Hikma Pharmaceuticals GABA Receptor Modulators Product Offered
11.5.3 Hikma Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Hikma Pharmaceuticals Main Business Overview
11.5.5 Hikma Pharmaceuticals Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi GABA Receptor Modulators Product Offered
11.6.3 Fresenius Kabi GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 B. Braun
11.7.1 B. Braun Company Information
11.7.2 B. Braun GABA Receptor Modulators Product Offered
11.7.3 B. Braun GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 B. Braun Main Business Overview
11.7.5 B. Braun Latest Developments
11.8 UCB
11.8.1 UCB Company Information
11.8.2 UCB GABA Receptor Modulators Product Offered
11.8.3 UCB GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 UCB Main Business Overview
11.8.5 UCB Latest Developments
11.9 Neurelis
11.9.1 Neurelis Company Information
11.9.2 Neurelis GABA Receptor Modulators Product Offered
11.9.3 Neurelis GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Neurelis Main Business Overview
11.9.5 Neurelis Latest Developments
11.10 Eagle Pharmaceuticals
11.10.1 Eagle Pharmaceuticals Company Information
11.10.2 Eagle Pharmaceuticals GABA Receptor Modulators Product Offered
11.10.3 Eagle Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eagle Pharmaceuticals Main Business Overview
11.10.5 Eagle Pharmaceuticals Latest Developments
11.11 Cosette Pharmaceuticals
11.11.1 Cosette Pharmaceuticals Company Information
11.11.2 Cosette Pharmaceuticals GABA Receptor Modulators Product Offered
11.11.3 Cosette Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cosette Pharmaceuticals Main Business Overview
11.11.5 Cosette Pharmaceuticals Latest Developments
11.12 Supernus Pharmaceuticals
11.12.1 Supernus Pharmaceuticals Company Information
11.12.2 Supernus Pharmaceuticals GABA Receptor Modulators Product Offered
11.12.3 Supernus Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Supernus Pharmaceuticals Main Business Overview
11.12.5 Supernus Pharmaceuticals Latest Developments
11.13 Biogen
11.13.1 Biogen Company Information
11.13.2 Biogen GABA Receptor Modulators Product Offered
11.13.3 Biogen GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Biogen Main Business Overview
11.13.5 Biogen Latest Developments
11.14 Immedica Pharma
11.14.1 Immedica Pharma Company Information
11.14.2 Immedica Pharma GABA Receptor Modulators Product Offered
11.14.3 Immedica Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Immedica Pharma Main Business Overview
11.14.5 Immedica Pharma Latest Developments
11.15 Jazz Pharmaceuticals
11.15.1 Jazz Pharmaceuticals Company Information
11.15.2 Jazz Pharmaceuticals GABA Receptor Modulators Product Offered
11.15.3 Jazz Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Jazz Pharmaceuticals Main Business Overview
11.15.5 Jazz Pharmaceuticals Latest Developments
11.16 Alkermes
11.16.1 Alkermes Company Information
11.16.2 Alkermes GABA Receptor Modulators Product Offered
11.16.3 Alkermes GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Alkermes Main Business Overview
11.16.5 Alkermes Latest Developments
11.17 Amneal Pharmaceuticals
11.17.1 Amneal Pharmaceuticals Company Information
11.17.2 Amneal Pharmaceuticals GABA Receptor Modulators Product Offered
11.17.3 Amneal Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Amneal Pharmaceuticals Main Business Overview
11.17.5 Amneal Pharmaceuticals Latest Developments
11.18 Azurity Pharmaceuticals
11.18.1 Azurity Pharmaceuticals Company Information
11.18.2 Azurity Pharmaceuticals GABA Receptor Modulators Product Offered
11.18.3 Azurity Pharmaceuticals GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Azurity Pharmaceuticals Main Business Overview
11.18.5 Azurity Pharmaceuticals Latest Developments
11.19 Piramal Pharma
11.19.1 Piramal Pharma Company Information
11.19.2 Piramal Pharma GABA Receptor Modulators Product Offered
11.19.3 Piramal Pharma GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Piramal Pharma Main Business Overview
11.19.5 Piramal Pharma Latest Developments
11.20 Humanwell Healthcare Group
11.20.1 Humanwell Healthcare Group Company Information
11.20.2 Humanwell Healthcare Group GABA Receptor Modulators Product Offered
11.20.3 Humanwell Healthcare Group GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Humanwell Healthcare Group Main Business Overview
11.20.5 Humanwell Healthcare Group Latest Developments
11.21 Jiangsu Nhwa Pharmaceutical
11.21.1 Jiangsu Nhwa Pharmaceutical Company Information
11.21.2 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product Offered
11.21.3 Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
11.21.5 Jiangsu Nhwa Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GABA Receptor Modulators Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. GABA Receptor Modulators Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GABAA Receptor Modulators
Table 4. Major Players of GABAB Receptor Modulators
Table 5. GABA Receptor Modulators Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 7. Global GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Benzodiazepines
Table 9. Major Players of Z-drugs
Table 10. Major Players of Barbiturates
Table 11. Major Players of Other
Table 12. GABA Receptor Modulators Market Size CAGR by Pharmacological Class (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global GABA Receptor Modulators Market Size by Pharmacological Class (2021-2026) & ($ millions)
Table 14. Global GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2021-2026)
Table 15. Major Players of Tablets and Capsules
Table 16. Major Players of Oral Liquids and Suspensions
Table 17. Major Players of Injectable Solutions
Table 18. Major Players of Other
Table 19. GABA Receptor Modulators Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global GABA Receptor Modulators Market Size by Dosage Form (2021-2026) & ($ millions)
Table 21. Global GABA Receptor Modulators Market Size Market Share by Dosage Form (2021-2026)
Table 22. GABA Receptor Modulators Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 24. Global GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Table 25. Global GABA Receptor Modulators Revenue by Player (2021-2026) & ($ millions)
Table 26. Global GABA Receptor Modulators Revenue Market Share by Player (2021-2026)
Table 27. GABA Receptor Modulators Key Players Head office and Products Offered
Table 28. GABA Receptor Modulators Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global GABA Receptor Modulators Market Size by Region (2021-2026) & ($ millions)
Table 32. Global GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Table 33. Global GABA Receptor Modulators Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global GABA Receptor Modulators Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas GABA Receptor Modulators Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas GABA Receptor Modulators Market Size Market Share by Country (2021-2026)
Table 37. Americas GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Table 39. Americas GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Table 41. APAC GABA Receptor Modulators Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Table 43. APAC GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe GABA Receptor Modulators Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe GABA Receptor Modulators Market Size Market Share by Country (2021-2026)
Table 47. Europe GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa GABA Receptor Modulators Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of GABA Receptor Modulators
Table 53. Key Market Challenges & Risks of GABA Receptor Modulators
Table 54. Key Industry Trends of GABA Receptor Modulators
Table 55. Global GABA Receptor Modulators Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global GABA Receptor Modulators Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global GABA Receptor Modulators Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global GABA Receptor Modulators Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Pfizer Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 60. Pfizer GABA Receptor Modulators Product Offered
Table 61. Pfizer GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Pfizer Main Business
Table 63. Pfizer Latest Developments
Table 64. Viatris Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 65. Viatris GABA Receptor Modulators Product Offered
Table 66. Viatris GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Viatris Main Business
Table 68. Viatris Latest Developments
Table 69. Teva Pharmaceutical Industries Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 70. Teva Pharmaceutical Industries GABA Receptor Modulators Product Offered
Table 71. Teva Pharmaceutical Industries GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Teva Pharmaceutical Industries Main Business
Table 73. Teva Pharmaceutical Industries Latest Developments
Table 74. Sandoz Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 75. Sandoz GABA Receptor Modulators Product Offered
Table 76. Sandoz GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Sandoz Main Business
Table 78. Sandoz Latest Developments
Table 79. Hikma Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 80. Hikma Pharmaceuticals GABA Receptor Modulators Product Offered
Table 81. Hikma Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Hikma Pharmaceuticals Main Business
Table 83. Hikma Pharmaceuticals Latest Developments
Table 84. Fresenius Kabi Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 85. Fresenius Kabi GABA Receptor Modulators Product Offered
Table 86. Fresenius Kabi GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Fresenius Kabi Main Business
Table 88. Fresenius Kabi Latest Developments
Table 89. B. Braun Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 90. B. Braun GABA Receptor Modulators Product Offered
Table 91. B. Braun GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. B. Braun Main Business
Table 93. B. Braun Latest Developments
Table 94. UCB Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 95. UCB GABA Receptor Modulators Product Offered
Table 96. UCB GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. UCB Main Business
Table 98. UCB Latest Developments
Table 99. Neurelis Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 100. Neurelis GABA Receptor Modulators Product Offered
Table 101. Neurelis GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Neurelis Main Business
Table 103. Neurelis Latest Developments
Table 104. Eagle Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 105. Eagle Pharmaceuticals GABA Receptor Modulators Product Offered
Table 106. Eagle Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Eagle Pharmaceuticals Main Business
Table 108. Eagle Pharmaceuticals Latest Developments
Table 109. Cosette Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 110. Cosette Pharmaceuticals GABA Receptor Modulators Product Offered
Table 111. Cosette Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Cosette Pharmaceuticals Main Business
Table 113. Cosette Pharmaceuticals Latest Developments
Table 114. Supernus Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 115. Supernus Pharmaceuticals GABA Receptor Modulators Product Offered
Table 116. Supernus Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Supernus Pharmaceuticals Main Business
Table 118. Supernus Pharmaceuticals Latest Developments
Table 119. Biogen Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 120. Biogen GABA Receptor Modulators Product Offered
Table 121. Biogen GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Biogen Main Business
Table 123. Biogen Latest Developments
Table 124. Immedica Pharma Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 125. Immedica Pharma GABA Receptor Modulators Product Offered
Table 126. Immedica Pharma GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Immedica Pharma Main Business
Table 128. Immedica Pharma Latest Developments
Table 129. Jazz Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 130. Jazz Pharmaceuticals GABA Receptor Modulators Product Offered
Table 131. Jazz Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Jazz Pharmaceuticals Main Business
Table 133. Jazz Pharmaceuticals Latest Developments
Table 134. Alkermes Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 135. Alkermes GABA Receptor Modulators Product Offered
Table 136. Alkermes GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Alkermes Main Business
Table 138. Alkermes Latest Developments
Table 139. Amneal Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 140. Amneal Pharmaceuticals GABA Receptor Modulators Product Offered
Table 141. Amneal Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Amneal Pharmaceuticals Main Business
Table 143. Amneal Pharmaceuticals Latest Developments
Table 144. Azurity Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 145. Azurity Pharmaceuticals GABA Receptor Modulators Product Offered
Table 146. Azurity Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Azurity Pharmaceuticals Main Business
Table 148. Azurity Pharmaceuticals Latest Developments
Table 149. Piramal Pharma Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 150. Piramal Pharma GABA Receptor Modulators Product Offered
Table 151. Piramal Pharma GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Piramal Pharma Main Business
Table 153. Piramal Pharma Latest Developments
Table 154. Humanwell Healthcare Group Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 155. Humanwell Healthcare Group GABA Receptor Modulators Product Offered
Table 156. Humanwell Healthcare Group GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Humanwell Healthcare Group Main Business
Table 158. Humanwell Healthcare Group Latest Developments
Table 159. Jiangsu Nhwa Pharmaceutical Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 160. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product Offered
Table 161. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. Jiangsu Nhwa Pharmaceutical Main Business
Table 163. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 1. GABA Receptor Modulators Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. GABA Receptor Modulators Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of GABAA Receptor Modulators
Table 4. Major Players of GABAB Receptor Modulators
Table 5. GABA Receptor Modulators Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 7. Global GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Benzodiazepines
Table 9. Major Players of Z-drugs
Table 10. Major Players of Barbiturates
Table 11. Major Players of Other
Table 12. GABA Receptor Modulators Market Size CAGR by Pharmacological Class (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global GABA Receptor Modulators Market Size by Pharmacological Class (2021-2026) & ($ millions)
Table 14. Global GABA Receptor Modulators Market Size Market Share by Pharmacological Class (2021-2026)
Table 15. Major Players of Tablets and Capsules
Table 16. Major Players of Oral Liquids and Suspensions
Table 17. Major Players of Injectable Solutions
Table 18. Major Players of Other
Table 19. GABA Receptor Modulators Market Size CAGR by Dosage Form (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global GABA Receptor Modulators Market Size by Dosage Form (2021-2026) & ($ millions)
Table 21. Global GABA Receptor Modulators Market Size Market Share by Dosage Form (2021-2026)
Table 22. GABA Receptor Modulators Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 24. Global GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Table 25. Global GABA Receptor Modulators Revenue by Player (2021-2026) & ($ millions)
Table 26. Global GABA Receptor Modulators Revenue Market Share by Player (2021-2026)
Table 27. GABA Receptor Modulators Key Players Head office and Products Offered
Table 28. GABA Receptor Modulators Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global GABA Receptor Modulators Market Size by Region (2021-2026) & ($ millions)
Table 32. Global GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Table 33. Global GABA Receptor Modulators Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global GABA Receptor Modulators Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas GABA Receptor Modulators Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas GABA Receptor Modulators Market Size Market Share by Country (2021-2026)
Table 37. Americas GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Table 39. Americas GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Table 41. APAC GABA Receptor Modulators Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Table 43. APAC GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe GABA Receptor Modulators Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe GABA Receptor Modulators Market Size Market Share by Country (2021-2026)
Table 47. Europe GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa GABA Receptor Modulators Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa GABA Receptor Modulators Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa GABA Receptor Modulators Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of GABA Receptor Modulators
Table 53. Key Market Challenges & Risks of GABA Receptor Modulators
Table 54. Key Industry Trends of GABA Receptor Modulators
Table 55. Global GABA Receptor Modulators Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global GABA Receptor Modulators Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global GABA Receptor Modulators Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global GABA Receptor Modulators Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Pfizer Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 60. Pfizer GABA Receptor Modulators Product Offered
Table 61. Pfizer GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Pfizer Main Business
Table 63. Pfizer Latest Developments
Table 64. Viatris Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 65. Viatris GABA Receptor Modulators Product Offered
Table 66. Viatris GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Viatris Main Business
Table 68. Viatris Latest Developments
Table 69. Teva Pharmaceutical Industries Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 70. Teva Pharmaceutical Industries GABA Receptor Modulators Product Offered
Table 71. Teva Pharmaceutical Industries GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Teva Pharmaceutical Industries Main Business
Table 73. Teva Pharmaceutical Industries Latest Developments
Table 74. Sandoz Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 75. Sandoz GABA Receptor Modulators Product Offered
Table 76. Sandoz GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Sandoz Main Business
Table 78. Sandoz Latest Developments
Table 79. Hikma Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 80. Hikma Pharmaceuticals GABA Receptor Modulators Product Offered
Table 81. Hikma Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Hikma Pharmaceuticals Main Business
Table 83. Hikma Pharmaceuticals Latest Developments
Table 84. Fresenius Kabi Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 85. Fresenius Kabi GABA Receptor Modulators Product Offered
Table 86. Fresenius Kabi GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. Fresenius Kabi Main Business
Table 88. Fresenius Kabi Latest Developments
Table 89. B. Braun Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 90. B. Braun GABA Receptor Modulators Product Offered
Table 91. B. Braun GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. B. Braun Main Business
Table 93. B. Braun Latest Developments
Table 94. UCB Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 95. UCB GABA Receptor Modulators Product Offered
Table 96. UCB GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. UCB Main Business
Table 98. UCB Latest Developments
Table 99. Neurelis Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 100. Neurelis GABA Receptor Modulators Product Offered
Table 101. Neurelis GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Neurelis Main Business
Table 103. Neurelis Latest Developments
Table 104. Eagle Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 105. Eagle Pharmaceuticals GABA Receptor Modulators Product Offered
Table 106. Eagle Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. Eagle Pharmaceuticals Main Business
Table 108. Eagle Pharmaceuticals Latest Developments
Table 109. Cosette Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 110. Cosette Pharmaceuticals GABA Receptor Modulators Product Offered
Table 111. Cosette Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Cosette Pharmaceuticals Main Business
Table 113. Cosette Pharmaceuticals Latest Developments
Table 114. Supernus Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 115. Supernus Pharmaceuticals GABA Receptor Modulators Product Offered
Table 116. Supernus Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. Supernus Pharmaceuticals Main Business
Table 118. Supernus Pharmaceuticals Latest Developments
Table 119. Biogen Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 120. Biogen GABA Receptor Modulators Product Offered
Table 121. Biogen GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Biogen Main Business
Table 123. Biogen Latest Developments
Table 124. Immedica Pharma Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 125. Immedica Pharma GABA Receptor Modulators Product Offered
Table 126. Immedica Pharma GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Immedica Pharma Main Business
Table 128. Immedica Pharma Latest Developments
Table 129. Jazz Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 130. Jazz Pharmaceuticals GABA Receptor Modulators Product Offered
Table 131. Jazz Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Jazz Pharmaceuticals Main Business
Table 133. Jazz Pharmaceuticals Latest Developments
Table 134. Alkermes Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 135. Alkermes GABA Receptor Modulators Product Offered
Table 136. Alkermes GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Alkermes Main Business
Table 138. Alkermes Latest Developments
Table 139. Amneal Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 140. Amneal Pharmaceuticals GABA Receptor Modulators Product Offered
Table 141. Amneal Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Amneal Pharmaceuticals Main Business
Table 143. Amneal Pharmaceuticals Latest Developments
Table 144. Azurity Pharmaceuticals Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 145. Azurity Pharmaceuticals GABA Receptor Modulators Product Offered
Table 146. Azurity Pharmaceuticals GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Azurity Pharmaceuticals Main Business
Table 148. Azurity Pharmaceuticals Latest Developments
Table 149. Piramal Pharma Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 150. Piramal Pharma GABA Receptor Modulators Product Offered
Table 151. Piramal Pharma GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Piramal Pharma Main Business
Table 153. Piramal Pharma Latest Developments
Table 154. Humanwell Healthcare Group Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 155. Humanwell Healthcare Group GABA Receptor Modulators Product Offered
Table 156. Humanwell Healthcare Group GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Humanwell Healthcare Group Main Business
Table 158. Humanwell Healthcare Group Latest Developments
Table 159. Jiangsu Nhwa Pharmaceutical Details, Company Type, GABA Receptor Modulators Area Served and Its Competitors
Table 160. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Product Offered
Table 161. Jiangsu Nhwa Pharmaceutical GABA Receptor Modulators Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. Jiangsu Nhwa Pharmaceutical Main Business
Table 163. Jiangsu Nhwa Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. GABA Receptor Modulators Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GABA Receptor Modulators Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. GABA Receptor Modulators Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. GABA Receptor Modulators Sales Market Share by Country/Region (2025)
Figure 8. GABA Receptor Modulators Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global GABA Receptor Modulators Market Size Market Share by Type in 2025
Figure 10. Global GABA Receptor Modulators Market Size Market Share by Pharmacological Class in 2025
Figure 11. Global GABA Receptor Modulators Market Size Market Share by Dosage Form in 2025
Figure 12. GABA Receptor Modulators in Hospital
Figure 13. Global GABA Receptor Modulators Market: Hospital (2021-2026) & ($ millions)
Figure 14. GABA Receptor Modulators in Clinic
Figure 15. Global GABA Receptor Modulators Market: Clinic (2021-2026) & ($ millions)
Figure 16. GABA Receptor Modulators in Others
Figure 17. Global GABA Receptor Modulators Market: Others (2021-2026) & ($ millions)
Figure 18. Global GABA Receptor Modulators Market Size Market Share by Application in 2025
Figure 19. Global GABA Receptor Modulators Revenue Market Share by Player in 2025
Figure 20. Global GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Figure 21. Americas GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 22. APAC GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 23. Europe GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 25. Americas GABA Receptor Modulators Value Market Share by Country in 2025
Figure 26. United States GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC GABA Receptor Modulators Market Size Market Share by Region in 2025
Figure 31. APAC GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Figure 32. APAC GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Figure 33. China GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 37. India GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe GABA Receptor Modulators Market Size Market Share by Country in 2025
Figure 40. Europe GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Figure 41. Europe GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Figure 42. Germany GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 43. France GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 44. UK GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Figure 50. Egypt GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 56. APAC GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 57. Europe GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 59. United States GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 60. Canada GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 61. Mexico GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 62. Brazil GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 63. China GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 64. Japan GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 65. Korea GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 67. India GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 68. Australia GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 69. Germany GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 70. France GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 71. UK GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 72. Italy GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 73. Russia GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 74. Egypt GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 75. South Africa GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 76. Israel GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 77. Turkey GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 78. Global GABA Receptor Modulators Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global GABA Receptor Modulators Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 1. GABA Receptor Modulators Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GABA Receptor Modulators Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. GABA Receptor Modulators Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. GABA Receptor Modulators Sales Market Share by Country/Region (2025)
Figure 8. GABA Receptor Modulators Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global GABA Receptor Modulators Market Size Market Share by Type in 2025
Figure 10. Global GABA Receptor Modulators Market Size Market Share by Pharmacological Class in 2025
Figure 11. Global GABA Receptor Modulators Market Size Market Share by Dosage Form in 2025
Figure 12. GABA Receptor Modulators in Hospital
Figure 13. Global GABA Receptor Modulators Market: Hospital (2021-2026) & ($ millions)
Figure 14. GABA Receptor Modulators in Clinic
Figure 15. Global GABA Receptor Modulators Market: Clinic (2021-2026) & ($ millions)
Figure 16. GABA Receptor Modulators in Others
Figure 17. Global GABA Receptor Modulators Market: Others (2021-2026) & ($ millions)
Figure 18. Global GABA Receptor Modulators Market Size Market Share by Application in 2025
Figure 19. Global GABA Receptor Modulators Revenue Market Share by Player in 2025
Figure 20. Global GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Figure 21. Americas GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 22. APAC GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 23. Europe GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa GABA Receptor Modulators Market Size 2021-2026 ($ millions)
Figure 25. Americas GABA Receptor Modulators Value Market Share by Country in 2025
Figure 26. United States GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC GABA Receptor Modulators Market Size Market Share by Region in 2025
Figure 31. APAC GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Figure 32. APAC GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Figure 33. China GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 37. India GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe GABA Receptor Modulators Market Size Market Share by Country in 2025
Figure 40. Europe GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Figure 41. Europe GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Figure 42. Germany GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 43. France GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 44. UK GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa GABA Receptor Modulators Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa GABA Receptor Modulators Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa GABA Receptor Modulators Market Size Market Share by Application (2021-2026)
Figure 50. Egypt GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries GABA Receptor Modulators Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 56. APAC GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 57. Europe GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 59. United States GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 60. Canada GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 61. Mexico GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 62. Brazil GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 63. China GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 64. Japan GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 65. Korea GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 67. India GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 68. Australia GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 69. Germany GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 70. France GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 71. UK GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 72. Italy GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 73. Russia GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 74. Egypt GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 75. South Africa GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 76. Israel GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 77. Turkey GABA Receptor Modulators Market Size 2027-2032 ($ millions)
Figure 78. Global GABA Receptor Modulators Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global GABA Receptor Modulators Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries GABA Receptor Modulators Market Size 2027-2032 ($ millions)
